Perspectives on the management of hypertension in Japan

References

• Tocci G, Ferrucci A, Pontremoli R, et al. Blood pressure levels and control in Italy: comprehensive analysis of clinical data from 2000–2005 and 2005–2011 hypertension surveys. J Hum Hypertens. 2015;29:696–701.
   PubMed Web of Science ®Google Scholar
• Banegas JR, Segura J, Ruilope LM, et al. Blood pressure control and physician management of hypertension in hospital hypertension units in Spain. Hypertension. 2004;43:1338–1344.
   PubMed Web of Science ®Google Scholar
• Blacher J, Peroz-Froz J, Huberman JP, et al. Ambulatory hypertensive patients treated by cardiologists in France. Arch Cardiovasc Dis. 2013;106:86–92.
   PubMed Web of Science ®Google Scholar
• Collaboration, NCDRF. Long-term and recent trends in hypertension awareness, treatment, and control in 12 high-income countries: an analysis of 123 nationally representative surveys. Lancet. 2019;394:639–651.
   PubMed Web of Science ®Google Scholar
• Ikeda N, Inoue M, Iso H, et al. Adult mortality attributable to preventable risk factors for non-communicable diseases and injuries in Japan: a comparative risk assessment. PLoS Med. 2012;9:e1001160.
   PubMed Web of Science ®Google Scholar
• Umemura S, Arima H, Arima S, et al. The Japanese Society of Hypertension guidelines for the management of hypertension (JSH 2019). Hypertens Res. 2019;42:1235–1481.
   PubMed Web of Science ®Google Scholar
• Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines. Hypertension. 2018;71:e13–e115.
   PubMed Web of Science ®Google Scholar
• Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension: the task force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension. J Hypertens. 2018;36:1953–2041.
   PubMed Web of Science ®Google Scholar
• Tocci G, Presta V, Figliuzzi I, et al. Reclassification of hypertensive outpatients according to new US guidelines on high blood pressure. Am J Hypertens. 2019;32:77–87.
   PubMed Web of Science ®Google Scholar
• Vaucher J, Marques-Vidal P, Waeber G, et al. Population impact of the 2017 ACC/AHA guidelines compared with the 2013 ESH/ESC guidelines for hypertension management. Eur J Prev Cardiol. 2018;25:1111–1113.
   PubMed Web of Science ®Google Scholar
• Ishikawa J, Hoshide S, Eguchi K, et al. Nighttime home blood pressure and the risk of hypertensive target organ damage. Hypertension. 2012;60:921–928.
   PubMed Web of Science ®Google Scholar
• Law MR, Morris JK, Wald NJ. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ. 2009;338:b1665.
   PubMed Web of Science ®Google Scholar
• Ohishi M, Yoshida T, Oh A, et al. Analysis of antihypertensive treatment using real-world Japanese data – the retrospective study of antihypertensives for lowering blood pressure (REAL) study. Hypertens Res. 2019;42:1057–1067.
   PubMed Web of Science ®Google Scholar
• Li EC, Heran BS, Wright JM. Angiotensin converting enzyme (ACE) inhibitors versus angiotensin receptor blockers for primary hypertension. Cochrane Database Syst Rev. 2014;(8):CD009096.
   PubMed Web of Science ®Google Scholar
• McDowell SE, Coleman JJ, Ferner RE. Systematic review and meta-analysis of ethnic differences in risks of adverse reactions to drugs used in cardiovascular medicine. BMJ. 2006;332:1177–1181.
   PubMed Web of Science ®Google Scholar
• Elliott WJ, Meyer PM. Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis. Lancet. 2007;369:201–207.
   PubMed Web of Science ®Google Scholar
• Mancia G, Grassi G, Zanchetti A. New-onset diabetes and antihypertensive drugs. J Hypertens. 2006;24:3–10.
   PubMed Web of Science ®Google Scholar
• Klingbeil AU, Schneider M, Martus P, et al. A meta-analysis of the effects of treatment on left ventricular mass in essential hypertension. Am J Med. 2003;115:41–46.
   PubMed Web of Science ®Google Scholar
• Lindholm LH, Carlberg B, Samuelsson O. Should beta blockers remain first choice in the treatment of primary hypertension? A meta-analysis. Lancet. 2005;366:1545–1553.
   PubMed Web of Science ®Google Scholar
• Wiysonge CS, Bradley HA, Volmink J, et al. Beta-blockers for hypertension. Cochrane Database Syst Rev. 2017;1:CD002003.
   PubMedGoogle Scholar
• Ueshima H. Explanation for the Japanese paradox: prevention of increase in coronary heart disease and reduction in stroke. J Atheroscler Thromb. 2007;14:278–286.
   PubMed Web of Science ®Google Scholar
• Kimura Y, Takishita S, Muratani H, et al. Demographic study of first-ever stroke and acute myocardial infarction in Okinawa, Japan. Int Med. 1998;37:736–745.
   PubMed Web of Science ®Google Scholar
• Kitamura A, Sato S, Kiyama M, et al. Trends in the incidence of coronary heart disease and stroke and their risk factors in Japan, 1964 to 2003: the Akita-Osaka study. J Am Coll Cardiol. 2008;52:71–79.
   PubMed Web of Science ®Google Scholar
• Hata J, Ninomiya T, Hirakawa Y, et al. Secular trends in cardiovascular disease and its risk factors in Japanese: half-century data from the Hisayama study (1961–2009). Circulation. 2013;128:1198–1205.
   PubMed Web of Science ®Google Scholar
• Shimamoto K, Ando K, Fujita T, et al. The Japanese Society of Hypertension guidelines for the management of hypertension (JSH 2014). Hypertens Res. 2014;37:253–390.
   PubMed Web of Science ®Google Scholar
• Musini VM, Nazer M, Bassett K, et al. Blood pressure-lowering efficacy of monotherapy with thiazide diuretics for primary hypertension. Cochrane Database Syst Rev. 2014;(5):CD003824.
   PubMed Web of Science ®Google Scholar
• Katsuya T, Ishikawa K, Sugimoto K, et al. Salt sensitivity of Japanese from the viewpoint of gene polymorphism. Hypertens Res. 2003;26:521–525.
   PubMed Web of Science ®Google Scholar
• Liu L, Xu B, Ju Y. Addition of spironolactone in patients with resistant hypertension: a meta-analysis of randomized controlled trials. Ann Clin Exp Hypertens. 2017;39:257–263.
   Google Scholar
• Zhao D, Liu H, Dong P, et al. A meta-analysis of add-on use of spironolactone in patients with resistant hypertension. Int J Cardiol. 2017;233:113–117.
   PubMed Web of Science ®Google Scholar
• Bundy JD, Li C, Stuchlik P, et al. Systolic blood pressure reduction and risk of cardiovascular disease and mortality: a systematic review and network meta-analysis. JAMA Cardiol. 2017;2:775–781.
   PubMed Web of Science ®Google Scholar
• Lindholm L, Ejlertsson G, Schersten B. High risk of cerebro-cardiovascular morbidity in well treated male hypertensives. A retrospective study of 40-59-year-old hypertensives in a Swedish primary care district. Acta Med Scand. 1984;216:251–259.
   PubMed Web of Science ®Google Scholar
• Clausen J, Jensen G. Blood pressure and mortality: an epidemiological survey with 10 years follow-up. J Hum Hypertens. 1992;6:53–59.
   PubMed Web of Science ®Google Scholar
• Andersson OK, Almgren T, Persson B, et al. Survival in treated hypertension: follow up study after two decades. BMJ. 1998;317:167–171.
   PubMed Web of Science ®Google Scholar
• Almgren T, Persson B, Wilhelmsen L, et al. Stroke and coronary heart disease in treated hypertension – a prospective cohort study over three decades. J Intern Med. 2005;257:496–502.
   PubMed Web of Science ®Google Scholar
• D’Agostino RB Sr., Vasan RS, Pencina MJ, et al. General cardiovascular risk profile for use in primary care: the Framingham heart study. Circulation. 2008;117:743–753.
   PubMed Web of Science ®Google Scholar
• Psaty BM, Furberg CD, Kuller LH, et al. Association between blood pressure level and the risk of myocardial infarction, stroke, and total mortality: the cardiovascular health study. Arch Internal Med. 2001;161:1183–1192.
   PubMed Web of Science ®Google Scholar
• Chambless LE, Folsom AR, Sharrett AR, et al. Coronary heart disease risk prediction in the Atherosclerosis Risk in Communities (ARIC) study. J Clin Epidemiol. 2003;56:880–890.
   PubMed Web of Science ®Google Scholar
• Lloyd-Jones DM, Braun LT, Ndumele CE, et al. Use of risk assessment tools to guide decision-making in the primary prevention of atherosclerotic cardiovascular disease: a special report from the American Heart Association and American College of Cardiology. J Am Coll Cardiol. 2019;73:3153–3167.
   PubMed Web of Science ®Google Scholar
• Asayama K, Ohkubo T, Yoshida S, et al. Stroke risk and antihypertensive drug treatment in the general population: the Japan arteriosclerosis longitudinal study. J Hypertens. 2009;27:357–364.
   PubMed Web of Science ®Google Scholar
• Yasui D, Asayama K, Ohkubo T, et al. Stroke risk in treated hypertension based on home blood pressure: the Ohasama study. Am J Hypertens. 2010;23:508–514.
   PubMed Web of Science ®Google Scholar
• Asayama K, Satoh M, Murakami Y, et al. Cardiovascular risk with and without antihypertensive drug treatment in the Japanese general population: participant-level meta-analysis. Hypertension. 2014;63:1189–1197.
   PubMed Web of Science ®Google Scholar
• Martin EA, Victor RG. Premise, promise, and potential limitations of invasive devices to treat hypertension. Curr Cardiol Rep. 2011;13:86–92.
   PubMedGoogle Scholar
• Montezano AC, Cat AND, Rios FJ, et al. Angiotensin II and vascular injury. Curr Hypertens Rep. 2014;16:431.
   PubMed Web of Science ®Google Scholar
• Higashi Y, Kihara Y, Noma K. Endothelial dysfunction and hypertension in aging. Hypertens Res. 2012;35:1039–1047.
   PubMed Web of Science ®Google Scholar
• Maruhashi T, Soga J, Fujimura N, et al. Endothelial function is impaired in patients receiving antihypertensive drug treatment regardless of blood pressure level: FMD-J study (flow-mediated dilation Japan). Hypertension. 2017;70:790–797.
   PubMed Web of Science ®Google Scholar
• Harrison DG. The mosaic theory revisited: common molecular mechanisms coordinating diverse organ and cellular events in hypertension. J Am Soc Hypertens. 2013;7:68–74.
   PubMed Web of Science ®Google Scholar
• Vasan RS, Larson MG, Leip EP, et al. Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med. 2001;345:1291–1297.
   PubMed Web of Science ®Google Scholar
• Egan BM, Stevens-Fabry S. Prehypertension–prevalence, health risks, and management strategies. Nat Rev Cardiology. 2015;12:289–300.
   PubMed Web of Science ®Google Scholar
• Vasan RS, Larson MG, Leip EP, et al. Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham heart study: a cohort study. Lancet. 2001;358:1682–1686.
   PubMed Web of Science ®Google Scholar
• Niiranen TJ, Larson MG, McCabe EL, et al. Prognosis of prehypertension without progression to hypertension. Circulation. 2017;136:1262–1264.
   PubMed Web of Science ®Google Scholar
• Dyer AR, Liu K, Walsh M, et al. Ten-year incidence of elevated blood pressure and its predictors: the CARDIA study. Coronary artery risk development in (young) adults. J Hum Hypertens. 1999;13:13–21.
   PubMed Web of Science ®Google Scholar
• Howard G, Banach M, Cushman M, et al. Is blood pressure control for stroke prevention the correct goal? The lost opportunity of preventing hypertension. Stroke. 2015;46:1595–1600.
   PubMed Web of Science ®Google Scholar
• Liu K, Colangelo LA, Daviglus ML, et al. Can antihypertensive treatment restore the risk of cardiovascular disease to ideal levels?: the Coronary Artery Risk Development in young adults (CARDIA) study and the Multi-Ethnic Study of Atherosclerosis (MESA). J Am Heart Assoc. 2015;4:e002275.
   PubMedGoogle Scholar
• Kario K. Nocturnal hypertension: new technology and evidence. Hypertension. 2018;71:997–1009.
   PubMed Web of Science ®Google Scholar
• Kario K, Shimbo D, Hoshide S, et al. Emergence of home blood pressure-guided management of hypertension based on global evidence. Hypertension. 2019;74:229–236. HYPERTENSIONAHA11912630.
   Web of Science ®Google Scholar
• Asayama K, Ohkubo T, Metoki H, et al. Cardiovascular outcomes in the first trial of antihypertensive therapy guided by self-measured home blood pressure. Hypertens Res. 2012;35:1102–1110.
   PubMed Web of Science ®Google Scholar
• Shirasaki O, Terada H, Niwano K, et al. The Japan home-health apparatus industrial association: investigation of home-use electronic sphygmomanometers. Blood Press Monit. 2001;6:303–307.
   PubMed Web of Science ®Google Scholar
• Ohkubo T, Imai Y, Tsuji I, et al. Home blood pressure measurement has a stronger predictive power for mortality than does screening blood pressure measurement: a population-based observation in Ohasama, Japan. J Hypertens. 1998;16:971–975.
   PubMed Web of Science ®Google Scholar
• Ohkubo T, Asayama K, Kikuya M, et al. How many times should blood pressure be measured at home for better prediction of stroke risk? Ten-year follow-up results from the Ohasama study. J Hypertens. 2004;22:1099–1104.
   PubMed Web of Science ®Google Scholar
• Shimada K, Kario K, Kushiro T, et al. Prognostic significance of on-treatment home and clinic blood pressure for predicting cardiovascular events in hypertensive patients in the HONEST study. J Hypertens. 2016;34:1520–1527.
   PubMed Web of Science ®Google Scholar
• Kario K, Saito I, Kushiro T, et al. Morning home blood pressure is a strong predictor of coronary artery disease: the HONEST study. J Am Coll Cardiol. 2016;67:1519–1527.
   PubMed Web of Science ®Google Scholar
• Kario K, Saito I, Kushiro T, et al. Home blood pressure and cardiovascular outcomes in patients during antihypertensive therapy: primary results of HONEST, a large-scale prospective, real-world observational study. Hypertension. 2014;64:989–996.
   PubMed Web of Science ®Google Scholar
• Hoshide S, Yano Y, Haimoto H, et al. Morning and evening home blood pressure and risks of incident stroke and coronary artery disease in the Japanese general practice population: the Japan morning surge-home blood pressure study. Hypertension. 2016;68:54–61.
   PubMed Web of Science ®Google Scholar
• Fujiwara T, Yano Y, Hoshide S, et al. Association of cardiovascular outcomes with masked hypertension defined by home blood pressure monitoring in a Japanese general practice population. JAMA Cardiol. 2018;3:583–590.
   PubMed Web of Science ®Google Scholar
• Satoh M, Maeda T, Hoshide S, et al. Is antihypertensive treatment based on home blood pressure recommended rather than that based on office blood pressure in adults with essential hypertension? (meta-analysis). Hypertens Res. 2019;42:807–816.
   PubMed Web of Science ®Google Scholar
• Hansen TW, Li Y, Boggia J, et al. Predictive role of the nighttime blood pressure. Hypertension. 2011;57:3–10.
   PubMed Web of Science ®Google Scholar
• Boggia J, Li Y, Thijs L, et al. Prognostic accuracy of day versus night ambulatory blood pressure: a cohort study. Lancet. 2007;370:1219–1229.
   PubMed Web of Science ®Google Scholar
• Kario K, Wang JG. Could 130/80 mm Hg be adopted as the diagnostic threshold and management goal of hypertension in consideration of the characteristics of Asian populations? Hypertension. 2018;71:979–984.
   PubMed Web of Science ®Google Scholar
• Li Y, Staessen JA, Lu L, et al. Is isolated nocturnal hypertension a novel clinical entity? Findings from a Chinese population study. Hypertension. 2007;50:333–339.
   PubMed Web of Science ®Google Scholar
• Fan HQ, Li Y, Thijs L, et al. Prognostic value of isolated nocturnal hypertension on ambulatory measurement in 8711 individuals from 10 populations. J Hypertens. 2010;28:2036–2045.
   PubMed Web of Science ®Google Scholar
• Uzu T, Kazembe FS, Ishikawa K, et al. High sodium sensitivity implicates nocturnal hypertension in essential hypertension. Hypertension. 1996;28:139–142.
   PubMed Web of Science ®Google Scholar
• Fukuda M, Munemura M, Usami T, et al. Nocturnal blood pressure is elevated with natriuresis and proteinuria as renal function deteriorates in nephropathy. Kidney Int. 2004;65:621–625.
   PubMed Web of Science ®Google Scholar
• Uzu T, Nishimura M, Fujii T, et al. Changes in the circadian rhythm of blood pressure in primary aldosteronism in response to dietary sodium restriction and adrenalectomy. J Hypertens. 1998;16:1745–1748.
   PubMed Web of Science ®Google Scholar
• Uzu T, Kimura G, Yamauchi A, et al. Enhanced sodium sensitivity and disturbed circadian rhythm of blood pressure in essential hypertension. J Hypertens. 2006;24:1627–1632.
   PubMed Web of Science ®Google Scholar
• Uzu T, Ishikawa K, Fujii T, et al. Sodium restriction shifts circadian rhythm of blood pressure from nondipper to dipper in essential hypertension. Circulation. 1997;96:1859–1862.
   PubMed Web of Science ®Google Scholar
• Uzu T, Kimura G. Diuretics shift circadian rhythm of blood pressure from nondipper to dipper in essential hypertension. Circulation. 1999;100:1635–1638.
   PubMed Web of Science ®Google Scholar
• Kario K. Key points of the Japanese Society of Hypertension guidelines for the management of hypertension in 2014. Pulse. 2015;3:35–47.
   PubMed Web of Science ®Google Scholar
• Rakugi H, Ito S, Itoh H, et al. Long-term phase 3 study of esaxerenone as mono or combination therapy with other antihypertensive drugs in patients with essential hypertension. Hypertens Res. 2019;42:1932–1941.
   Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Mojon A, et al. Influence of circadian time of hypertension treatment on cardiovascular risk: results of the MAPEC study. Chronobiol Int. 2010;27:1629–1651.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Mojon A, et al. Decreasing sleep-time blood pressure determined by ambulatory monitoring reduces cardiovascular risk. J Am Coll Cardiol. 2011;58:1165–1173.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Smolensky MH, et al. Chronotherapy with conventional blood pressure medications improves management of hypertension and reduces cardiovascular and stroke risks. Hypertens Res. 2016;39:277–292.
   PubMed Web of Science ®Google Scholar